Endogenous TNF Production Differs Between High and Low Diabetes Incidence Non-Obese Diabetic (NOD) Mice: Canberra 2601 Australia

References

• Pujol-Borrell R, Todd I, Doshi M, Bottazzo GF, Sutton R, Gray D. HLA class II induction in human islet cells by interferon-y plus tumour necrosis factor or lymphotoxin. Nature 1987; 326: 304–6
   PubMed Web of Science ®Google Scholar
• Campbell IL, Oxbrow L, West J, Harrison LC. Regulation of MHC protein expression in pancreatic β-cells by interferon-γ and tumor necrosis factor-α. Mol Endocrinol 1988; 2: 101–7
   PubMedGoogle Scholar
• Campbell IL, Cutri A, Wilkinson D, Boyd AW, Harrison LC. Intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by reovirus infection. Proc Natl Acad Sci USA 1989; 86: 4282–6
   PubMedGoogle Scholar
• Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J. Human tumor necrosis factor potentiates human interleu-kin 1-mediated rat pancreatic β-cell cytotoxity. J Immunol 1987; 139: 4077–82
   PubMed Web of Science ®Google Scholar
• Campbell IL, Iscaro A, Harrison LC. IFN-γ and tumor necrosis factor-α: cytotoxity to murine islets of Langerhans. J Immunol 1988; 141: 2325–29
   PubMed Web of Science ®Google Scholar
• Satoh J, Seino H, Tanaka S, Shintani S, Ohta S, Tamura K. Recombinant human tumor necrosis factor a suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest 1989; 84: 1345–8
   PubMed Web of Science ®Google Scholar
• Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and interleukin 1. Proc Natl Acad Sci USA 1990; 87: 968–72
   PubMed Web of Science ®Google Scholar
• Campbell IL, Oxbrow L, Harrison LC. Reduction in insulitis following administration of IFN-γ and TNF-α in the NOD mouse. J Autoimmunity 1990; 4: 249–62
   Google Scholar
• Satoh J, Seino H, Shintani S, Tanaka S-I, Ohteki T, Masuda T. Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor α. J. Immunol 1990; 145: 1395–9
   PubMed Web of Science ®Google Scholar
• Toyota T, Satoh J, Oya K, Shintani S, Okano T. Streptococcal preparation (OK-432) inhibits development of type 1 diabetes in NOD mice. Diabetes 1986; 35: 496–9
   PubMed Web of Science ®Google Scholar
• Setoguchi J, Hashiramoto K, Nakana K, Kitagawa Y, Nakamura N[Kanatsuna T. Prediction of insulin-dependent diabetes mellitus in non-obese diabetic mice by the endogenous tumor necrosis factor-alpha level. Diabetes Res 1992; 19: 63–7
   PubMedGoogle Scholar
• Spies TT, Morton CC, Nedospasov SA, Fiers W, Pious D, Strominger JL. Genes for the tumor necrosis factors a and p are linked to the major histocompatibility complex. Proc Natl Acad Sci USA 1986; 83: 8699–702
   PubMed Web of Science ®Google Scholar
• Browning JL, Ngam-Ek A, Lawton P, DeMarinis Tizard R, Chow EP. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 1993; 72: 847–56
   PubMed Web of Science ®Google Scholar
• Badenhoop K, Schwarz G, Trowsdale J, Lewis V, Usadel KH, Gale EAM. TNF-α gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1989; 32: 445–8
   PubMed Web of Science ®Google Scholar
• Sachs JA, Whichelow CE, Hitman GA, Niven M, Thode H, Meager A. The effect of HLA and insulin-dependent diabetes mellitus on the secretion levels of tumour necrosis factors alpha and beta and gamma interferon. Scand J Immunol 1990; 32: 703–8
   PubMedGoogle Scholar
• Tait BD, Harrison LC. Overview: the major histocompatibility complex and insulin dependent diabetes mellitus. In: Genetics of Diabetes Part I. Balliere's Clin Endocrinol Metab 1991; 5: 211–28
   PubMedGoogle Scholar
• Mølvig J, Pociot F, Baek L, Worsaae H, Wogensen LD, Christensen P. Monocyte function in IDDM patients and healthy individuals. Scand J Immunol 1990; 32: 297–311
   PubMedGoogle Scholar
• Pociot F, Mølvig J, Wogensen L, Worsaae H, Dalbøge H, Baek L, Nerup J. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 1991; 33: 37–9
   PubMed Web of Science ®Google Scholar
• Messer G, Spengler U, Jung MC, Honold G, Blomor K, Papor GR. Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymoprhism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med 1991; 173: 209–19
   PubMed Web of Science ®Google Scholar
• Baxter AG, Adams MA, Mandel TE. Comparison of high-and low-diabetes incidence mouse strains. Diabetes 1989; 38: 1296–300
   PubMedGoogle Scholar
• Serreze DV, Leiter EH. Defective activation of T suppressor cell function in nonobese diabetic mice. J Immunol 1988; 140: 3801–7
   PubMed Web of Science ®Google Scholar
• Strober W, James SP. Immunoregulatory function of human autoreactive T-cell lines and clones. Immunological Reviews 1990; 116: 117–38
   PubMedGoogle Scholar
• Freeman R, Wheeler J, Robertson H, Paes ML, Laidler J. In-vitro production of TNF-α in blood samples. Lancet 1990; 336: 312–13
   PubMedGoogle Scholar
• Flick DA, Gifford GE. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 1984; 68: 167–75
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Signore A, Williams AJK, Beales PE. NOD mouse colonies around the world –recent facts and figures. Immunol Today 1993; 14: 193–6
   PubMedGoogle Scholar
• Rasanen L, Hyoty H, Lento M, Kallioniemi O-P, Antonen J, Huupponen T. Defective autologous mixed leukocyte reaction in newly diagnosed type 1 diabetes mellitus. Clin Exp Immunol 1988; 71: 470–4
   PubMedGoogle Scholar
• Yokota S, Geppert TD, Lipsky PE. Enhancement of antigen-and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-α. J Immunol 1988; 149: 531–6
   Google Scholar
• Lee JC, Truneh A, Smith MF, Tsang KY. Induction of interleukin 2 receptor (TAC) by tumor necrosis factor in YT cells. J Immunol 1987; 139
   Google Scholar
• Leiter EH, Serreze DV. Autoimmune diabetes in the nonobese diabetic mouse: suppression of immune defects by bone marrow transplantation and implications for therapy. Clin Immunol and Immunopathol 1991; 59: 323–34
   PubMedGoogle Scholar
• Bateman A, Singh A, Krai T, Solomon S. The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 1989; 10: 92–112
   PubMed Web of Science ®Google Scholar